| 8.51 -0.37 (-4.17%) | 10-24 14:59 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 10.99 |
1-year : | 12.03 |
| Resists | First : | 9.4 |
Second : | 10.3 |
| Pivot price | 8.92 |
|||
| Supports | First : | 7.96 |
Second : | 6.63 |
| MAs | MA(5) : | 8.88 |
MA(20) : | 8.91 |
| MA(100) : | 7.56 |
MA(250) : | 9.15 |
|
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 21.7 |
D(3) : | 35.9 |
| RSI | RSI(14): 46.2 |
|||
| 52-week | High : | 21.14 | Low : | 0.18 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PIII ] has closed above bottom band by 0.5%. Bollinger Bands are 45.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 8.89 - 8.94 | 8.94 - 8.99 |
| Low: | 8.61 - 8.67 | 8.67 - 8.73 |
| Close: | 8.78 - 8.88 | 8.88 - 8.97 |
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Tue, 21 Oct 2025
P3 Health Partners (NASDAQ: PIII) sets Nov. 14 earnings release, call at 8:00am ET - Stock Titan
Wed, 17 Sep 2025
Population Health Leader P3 Health Partners to Present at Major Jefferies Healthcare Conference - Stock Titan
Sat, 16 Aug 2025
P3 Health Partners Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Mon, 28 Jul 2025
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc. - GlobeNewswire
Thu, 15 May 2025
P3 Health Partners Announces First Quarter 2025 Results - Business Wire
Wed, 14 May 2025
P3 Health Partners Inc (PIII) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 3 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 62.4 (%) |
| Held by Institutions | 10.6 (%) |
| Shares Short | 21 (K) |
| Shares Short P.Month | 25 (K) |
| EPS | -51.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.6 |
| Profit Margin | -10 % |
| Operating Margin | -9.6 % |
| Return on Assets (ttm) | -24.4 % |
| Return on Equity (ttm) | -141.6 % |
| Qtrly Rev. Growth | -6.2 % |
| Gross Profit (p.s.) | -22.55 |
| Sales Per Share | 446.48 |
| EBITDA (p.s.) | -70.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -130 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.17 |
| PEG Ratio | 0 |
| Price to Book value | 0.62 |
| Price to Sales | 0.01 |
| Price to Cash Flow | -0.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |